Neogen Salmonella Enrichment Supplement

Hazard statements (CLP)

H302, H318, H361d, H411

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

Classification of the substance or mixture Classification according to GB CLP (SI 2019:720 as amended) Acute toxicity (oral), Category 4 H302 Serious eye damage/eye irritation, Category 1 H318 Reproductive toxicity, Category 2 H361d Hazardous to the aquatic environment – Chronic Hazard, Category 2 H411 Full text of H- and EUH-statements: see section 16

Adverse physicochemical, human health and environmental effects

No additional information available

2.2 Label elements

Labelling according to GB CLP (SI 2019:720 as amended)

Hazard pictograms

GHS05 GHS07 GHS08 GHS09

Signal word

(GHS UK) Danger

Contains

Malachite green oxalate; Nalidixic acid; Streptomycin sesquisulfate hydrate

Hazard statements

H302 - Harmful if swallowed. H318 - Causes serious eye damage. H361d - Suspected of damaging the unborn child. H411 - Toxic to aquatic life with long lasting effects.

Precautionary statements

P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P273 - Avoid release to the environment. P280 - Wear protective gloves, protective clothing, eye protection, face protection and hearing protection.

Results of PBT and vPvB assessment

Component Substance(s) not meeting the PBT criteria of UK Malachite green oxalate, Nalidixic acid (389-08-2), Streptomycin sesquisulfate hydrate REACH regulation, in accordance with Annex XIII (3810-74-0) Substance(s) not meeting the vPvB criteria of UK Malachite green oxalate, Nalidixic acid (389-08-2), Streptomycin sesquisulfate hydrate REACH regulation, in accordance with Annex XIII (3810-74-0) Results of Endocrine Disruptor assessment Component Substance(s) not considered as endocrine disrupting. Malachite green oxalate, Streptomycin sesquisulfate hydrate(3810-74-0), Nalidixic They are not included in the list established in acid(389-08-2) accordance with Article 59(1) of UK REACH for having endocrine disrupting properties, nor identified as having endocrine disrupting properties in accordance with the criteria set out in GB BPR and GB PPP

2.1 Classification of the substance or mixture

Classification according to GB CLP (SI 2019:720 as amended) Acute toxicity (oral), Category 4 H302 Serious eye damage/eye irritation, Category 1 H318 Reproductive toxicity, Category 2 H361d Hazardous to the aquatic environment – Chronic Hazard, Category 2 H411 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available